DelSiTech

DelSiTech is a clinical-stage drug delivery company specializing in biodegradable silica-based controlled release technology for small molecule drugs, biologics, and vaccines. It collaborates with pharmaceutical and biotech companies to develop novel drug products, leveraging its proprietary Silica Matrix technology for controlled release of therapeutic agents. The company focuses on addressing high unmet clinical and commercial needs for patients.

Buy Funded Startups lists

Funding Round:

Funding Amount: €10M

Date: 16-Jan-2024

Investors: DRW Venture Capital LLC, Tolmar International Ltd

Markets: Pharmaceuticals, Biotechnology, Drug Delivery

HQ: Turku, Finland

Founded: 2001

Website: http://www.delsitech.com/

LinkedIn: https://fi.linkedin.com/company/delsitech-ltd

Twitter: https://twitter.com/DelSiTech

Instagram: